Fortinet Expands Its Secure Networking Portfolio to Further Drive the Convergence of Networking and Security 3-08-2023, 20:00

Descartes’ Study Reveals 65% of Companies Plan to Accelerate Supply Chain and Logistics Innovation Investment 30-01-2023, 18:45

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26